EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of modulating the extracellular matrix cross linkage by genipin on tumor cell resistance and survival in thioacetamide-induced hepatocellular carcinoma in rats

Hanan M Hassan, Mohammed Baradwan, Alaa Bagalagel, Reem Diri, Ahmed Basilim, Mohammed Z Nasrullah, Abdulhamid Althagafi, Hussam I Kutbi, Abdulaziz A Mohammed, Hanan M Alshan, Mohammed M H Al-Gayyar

PeerJ · 2025

DOI: 10.7717/peerj.19680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Hanan M Hassan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Biochemistry, Delta University for Science and Technology, Gamasa, Egypt. Hauptthemen laut MEDLINE: Iridoids, Carcinoma, Hepatocellular, Extracellular Matrix, Liver Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies on patients and rats with hepatocellular carcinoma (HCC) have shown significant changes in the extracellular matrix (ECM). Versican, a component of the ECM, forms extensive multimolecular interactions with other ECM components, particularly hyaluronan, through specific domains in its core protein. However, disturbances in the hyaluronan-versican interaction may affect cancer development. We aimed to examine the effect of modulating matrix cross-linkage between hyaluronan and versican using genipin on tumor cell survival, resistance, and renewal.

Methods

Following the induction of HCC in rats using thioacetamide, an oral dose of 10 mg/kg of genipin was administered. Liver impairment was evaluated by measuring serum α-fetoprotein (AFP) levels and examining liver sections stained with hematoxylin/eosin and anti-versican and anti-fibronectin antibodies. Additionally, hepatic expression levels of mRNA and proteins, including epidermal growth factor (EGF), epidermal growth factor receptor (EGFR), fibronectin, glycogen synthase kinase-3 beta (GSK-3β), protein kinase B (PKB), and versican, were analyzed.

Results

Genipin enhances rats’ survival, leading to reduction in serum AFP levels and number of hepatic nodules. Micro-imaging examinations reveal that genipin reduces vacuolated cytoplasm, apoptotic nuclei, and necrotic nodules. Additionally, it significantly lowers EGF, EGFR, fibronectin, GSK-3β, PKB, and versican expression levels.

Conclusion

Genipin may be considered novel anticancer agent with hepatoprotective effects. This is achieved by reducing versican-free forms. Additionally, genipin decreases tumor cells’ resistance by lowering the expression of EGF, EGFR, PKB, and GSK-3β. Finally, it reduces tumor cell survival by decreasing the expression of fibronectin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridoidsCarcinoma, HepatocellularExtracellular MatrixLiver NeoplasmsAnimalsThioacetamideRatsVersicansMaleCell SurvivalErbB ReceptorsHyaluronic Acidalpha-FetoproteinsFibronectinsGlycogen Synthase Kinase 3 betaEpidermal Growth Factor

Stichwörter der Autor:innen

Epidermal growth factor (EGF)Epidermal growth factor receptor (EGFR)FibronectinGenipinGlycogen synthase kinase-3 beta (GSK-3β)Hepatocellular carcinomaProtein kinase B (PKB)Versican

Substanzen

genipinIridoidsThioacetamideVersicansErbB ReceptorsHyaluronic Acidalpha-FetoproteinsFibronectinsGlycogen Synthase Kinase 3 betaEpidermal Growth Factor

Autor:innen und Institutionen

  • Department of Pharmacology and Biochemistry, Delta University for Science and Technology, Gamasa, Egypt.
  • Department of Medicinal Chemistry, King Abdul Aziz University, Jeddah, Saudi Arabia.
  • Department of Pharmacy Practice, Faculty of Pharmacy, King Abdul Aziz University, Jeddah, Saudi Arabia.
  • Department of Pharmacology and Toxicology, King Abdul Aziz University, Jeddah, Saudi Arabia.
  • Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of Biochemistry, Mansoura University, Mansoura, Egypt.

Zitieren

APA

Hassan, H. M., Baradwan, M., Bagalagel, A., Diri, R., Basilim, A., Nasrullah, M. Z., Althagafi, A., Kutbi, H. I., Mohammed, A. A., Alshan, H. M., & Al-Gayyar, M. M. H. (2025). Effect of modulating the extracellular matrix cross linkage by genipin on tumor cell resistance and survival in thioacetamide-induced hepatocellular carcinoma in rats. PeerJ. https://doi.org/10.7717/peerj.19680

Vancouver

Hassan HM, Baradwan M, Bagalagel A, Diri R, Basilim A, Nasrullah MZ, et al. Effect of modulating the extracellular matrix cross linkage by genipin on tumor cell resistance and survival in thioacetamide-induced hepatocellular carcinoma in rats. PeerJ. 2025. doi:10.7717/peerj.19680

BibTeX
@article{Hassan2025,
  author = {Hassan, Hanan M and Baradwan, Mohammed and Bagalagel, Alaa and Diri, Reem and Basilim, Ahmed and Nasrullah, Mohammed Z and Althagafi, Abdulhamid and Kutbi, Hussam I and Mohammed, Abdulaziz A and Alshan, Hanan M and Al-Gayyar, Mohammed M H},
  title = {Effect of modulating the extracellular matrix cross linkage by genipin on tumor cell resistance and survival in thioacetamide-induced hepatocellular carcinoma in rats},
  journal = {PeerJ},
  year = {2025},
  doi = {10.7717/peerj.19680}
}
Kostenlos starten →